Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
16,326
Total Claims
$1.1M
Drug Cost
601
Beneficiaries
$1,874
Cost/Patient
Risk Score Breakdown 29/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-25%
Opioid rate vs peers
1.7% vs 2.2% avg
+33%
Cost per patient vs peers
$1,874 vs $1,411 avg
+115%
Brand preference vs peers
22.8% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.7%
Opioid Rate
274
Opioid Claims
$76K
Opioid Cost
17.9%
Long-Acting Rate
Brand vs Generic
Brand: 3,679 claims · $812K
Generic: 12,451 claims · $299K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 891 | $267K |
| Oxycodone Hcl | 28 | $72K |
| Rivaroxaban | 87 | $31K |
| Insulin Glargine,hum.Rec.Anlog | 133 | $30K |
| Sitagliptin Phosphate | 67 | $23K |
| Semaglutide | 16 | $22K |
| Empagliflozin | 52 | $21K |
| Fluticasone/Umeclidin/Vilanter | 32 | $19K |
| Cariprazine Hcl | 23 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 53 | $17K |
| Mirabegron | 74 | $16K |
| Pen Needle,dual Safety,diabetc | 148 | $14K |
| Atorvastatin Calcium | 814 | $14K |
| Insulin Glargine,hum.Rec.Anlog | 70 | $13K |
| Insulin Aspart | 40 | $12K |
Prescribing Profile
Patient Profile
78
Avg Age
56%
Female
1.62
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About